Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH mutation testing in gliomas-where do we draw the line?

Neuro-oncology - 29 Nov 2017

Nassiri Farshad, Zadeh Gelareh, Aldape Kenneth

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Glioma
Share to Isocitrate Dehydrogenase
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nervous System

Source

Open in PubMed Open full text

Identifiers

PMID: 29140514
DOI: 10.1093/neuonc/nox164
PMCID: PMC5716201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH mutation testing in gliomas-where do we draw the line?PMID 29140514Read ↗

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencingSemantic proximity Read ↗

Glioma IDH1 mutation patterns off the beaten track.Semantic proximity Read ↗

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.Semantic proximity Read ↗

Molecular Testing of Brain TumorSemantic proximity Read ↗

Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?Semantic proximity Read ↗

CNS cancer: Breaking boundaries - IDH mutations in glioma.Semantic proximity Read ↗

Advances in the molecular genetics of gliomas — implications for classification and therapySemantic proximity Read ↗

Management of diffuse low-grade gliomas in adults — use of molecular diagnosticsSemantic proximity Read ↗

Molecular profiling of CNS tumors for the treatment and management of disease.Semantic proximity Read ↗

Updates on the WHO diagnosis of IDH-mutant glioma.Semantic proximity Read ↗

Molecular markers in gliomas: impact for the clinicianSemantic proximity Read ↗

Can my computer tell me if this tumor is IDH mutated?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.